The G protein-coupled receptor GPR34 - The past 20 years of a grownup

Pharmacol Ther. 2018 Sep:189:71-88. doi: 10.1016/j.pharmthera.2018.04.008. Epub 2018 Apr 22.

Abstract

Research on GPR34, which was discovered in 1999 as an orphan G protein-coupled receptor of the rhodopsin-like class, disclosed its physiologic relevance only piece by piece. Being present in all recent vertebrate genomes analyzed so far it seems to improve the fitness of species although it is not essential for life and reproduction as GPR34-deficient mice demonstrate. However, closer inspection of macrophages and microglia, where it is mainly expressed, revealed its relevance in immune cell function. Recent data clearly demonstrate that GPR34 function is required to arrest microglia in the M0 homeostatic non-phagocytic phenotype. Herein, we summarize the current knowledge on its evolution, genomic and structural organization, physiology, pharmacology and relevance in human diseases including neurodegenerative diseases and cancer, which accumulated over the last 20 years.

Keywords: Drug discovery; G protein-coupled receptor; GPR34; Microglia; Nucleotide receptor; Orphan GPCR.

Publication types

  • Historical Article
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Evolution, Molecular
  • Genomics
  • History, 20th Century
  • History, 21st Century
  • Humans
  • Phenotype
  • Receptors, Lysophospholipid / chemistry
  • Receptors, Lysophospholipid / history
  • Receptors, Lysophospholipid / physiology*

Substances

  • G-protein-coupled receptor 34
  • Receptors, Lysophospholipid